Ligand Pharmaceuticals News
Most Popular Ligand Pharmaceuticals Story
Promacta gets FDA approval
The FDA has approved GlaxoSmithKline and Ligand Pharmaceuticals' Promacta (eltrombopag). The drug treats a rare immune condition called thrombocytopenia purpura, in which a patient's immune system... Read more...
Latest Headlines
- November 21, 2008
- September 25, 2008
- September 9, 2008
- June 2, 2008
- January 31, 2007
- January 16, 2007
- September 13, 2006
- September 7, 2006
- September 6, 2006
- August 1, 2006
- June 27, 2006
- June 18, 2006
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
